These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor. Izzo E; Sanna PP; Koob GF Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056 [TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats. Diamant M; Kashtanov SI; Fodor M; de Wied D Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107 [TBL] [Abstract][Full Text] [Related]
6. Altered responsivity to central administrations of corticotropin-releasing factor in rats with a history of opiate exposures. Blatchford KE; Choi EA; McNally GP Behav Neurosci; 2006 Oct; 120(5):1169-74. PubMed ID: 17014268 [TBL] [Abstract][Full Text] [Related]
7. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes. Lu L; Liu Z; Huang M; Zhang Z J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338 [TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. Butler PD; Weiss JM; Stout JC; Nemeroff CB J Neurosci; 1990 Jan; 10(1):176-83. PubMed ID: 2299391 [TBL] [Abstract][Full Text] [Related]
10. Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior. Baldo BA; Kelley AE Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1232-42. PubMed ID: 11557632 [TBL] [Abstract][Full Text] [Related]
11. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity. Diamant M; de Wied D Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765 [TBL] [Abstract][Full Text] [Related]
13. Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors. Canales JJ; Iversen SD Synapse; 2000 Jun; 36(4):297-306. PubMed ID: 10819907 [TBL] [Abstract][Full Text] [Related]
14. CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats. Mönnikes H; Heymann-Mönnikes I; Taché Y Brain Res; 1992 Mar; 574(1-2):70-6. PubMed ID: 1638411 [TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing factor in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine balance. Chen YW; Rada PV; Bützler BP; Leibowitz SF; Hoebel BG Neuroscience; 2012 Mar; 206():155-66. PubMed ID: 22245501 [TBL] [Abstract][Full Text] [Related]
16. Effects of 5-HT-1A receptor agonists on CRF-induced behavior. Lazosky AJ; Britton DR Psychopharmacology (Berl); 1991; 104(1):132-6. PubMed ID: 1831906 [TBL] [Abstract][Full Text] [Related]
17. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. Diamant M; de Wied D Endocrinology; 1991 Jul; 129(1):446-54. PubMed ID: 2055199 [TBL] [Abstract][Full Text] [Related]
19. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Krahn DD; Gosnell BA; Levine AS; Morley JE Brain Res; 1988 Mar; 443(1-2):63-9. PubMed ID: 2834018 [TBL] [Abstract][Full Text] [Related]
20. Behavioral and physiological consequences of repeated daily intracerebroventricular injection of corticotropin-releasing factor in the rat. Buwalda B; Van Kalkeren AA; de Boer SF; Koolhaas JM Psychoneuroendocrinology; 1998 Apr; 23(3):205-18. PubMed ID: 9695127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]